Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease

被引:95
|
作者
Lin, Grace A.
Dudley, R. Adams
Redberg, Rita F.
机构
[1] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
关键词
D O I
10.1001/archinte.167.15.1604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous coronary intervention (PCI) is commonly performed in patients with stable coronary artery disease, despite current evidence suggesting that such patients derive minimal benefit from the procedure. We sought to determine the influences on cardiologists' decision to perform elective PCI in patients with stable coronary artery disease. Methods: We conducted a qualitative study using 3 focus groups of interventional and noninterventional cardiologists in California. Participants discussed issues surrounding the decision to perform PCI using hypothetical case scenarios. We analyzed the data according to the principles of grounded theory. Results: Despite acknowledging data showing that PCI offers no reduction in the risk of death or myocardial infarction in patients with stable coronary artery disease, cardiologists generally believed that PCI would benefit such patients. Reasons given for performing PCI included belief the benefits of treating ischemia and the open artery hypothesis, especially with drug-eluting stents; potential regret for not intervening if a cardiac event could be averted; alleviation of patient anxiety; and medicolegal considerations. Participants believed that, in patients undergoing coronary angiography, an "oculostenotic reflex" prevailed and all significant amenable stenoses would receive intervention, even in asymptomatic patients. Conclusions: The widespread application of PCI in stable coronary artery disease for indications unsupported by evidence may reflect discordance between cardiologists' clinical knowledge and their beliefs about the benefits of PCI. Nonclinical factors appear to have substantial influence on physician decision making. Future studies should focus on the development of methods to help providers more fully incorporate clinical evidence into their medical decision making.
引用
收藏
页码:1604 / 1609
页数:6
相关论文
共 50 条
  • [21] Optimal Achieved Lipid Profiles for Asian Patients With Stable Coronary Artery Disease After Percutaneous Coronary Interventions
    Huang, Chin-Chou
    Leu, Hsin-Bang
    Yin, Wei-Hsian
    Tseng, Wei-Kung
    Wu, Yen-Wen
    Lin, Tsung-Hsien
    Yeh, Hung-I
    Chang, Kuan-Cheng
    Wang, Ji-Hung
    Wu, Chau-Chung
    Chen, Jaw-Wen
    CIRCULATION, 2017, 136
  • [22] MICROEMBOLIZATION PREDICTS SUBCLINICAL MYONECROSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN DIABETIC PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Otto, Sylvia
    Seeber, Maria
    Fujita, Buntaro
    Ferrari, Markus
    Figulla, Hans R.
    Poerner, Tudor C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1619 - E1619
  • [23] Percutaneous Coronary Intervention with Stenting versus Coronary Artery Bypass Grafting in Stable Coronary Artery Disease
    Glenn, Ian C.
    Iacona, Gabriele M.
    Mangi, Abeel A.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021, 30 (03) : 221 - 227
  • [24] Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention
    Godino, Cosmo
    Colombo, Antonio
    Margonato, Alberto
    CLINICAL DRUG INVESTIGATION, 2017, 37 (02) : 105 - 120
  • [25] Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention
    Cosmo Godino
    Antonio Colombo
    Alberto Margonato
    Clinical Drug Investigation, 2017, 37 : 105 - 120
  • [26] The State of Percutaneous Intervention in Stable Coronary Artery Disease
    Caitlin Drescher
    Sunil V. Rao
    Current Atherosclerosis Reports, 2020, 22
  • [27] The State of Percutaneous Intervention in Stable Coronary Artery Disease
    Drescher, Caitlin
    Rao, Sunil V.
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (08)
  • [28] Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
    Hannan, Edward L.
    Wu, Yi-Feng
    Cozzens, Kimberly
    Tamis-Holland, Jacqueline
    Ling, Frederick S. K.
    Jacobs, Alice K.
    Venditti, Ferdinand J.
    Berger, Peter B.
    Walford, Gary
    King, Spencer B., III
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (03) : 159 - 167
  • [29] Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
    Edward L.Hannan
    Yi-Feng WU
    Kimberly Cozzens
    Jacqueline Tamis-Holland
    Frederick S.K.Ling
    Alice K.Jacobs
    Ferdinand J.Venditti
    Peter B.Berger
    Gary Walford
    Spencer B.King
    Journal of Geriatric Cardiology, 2021, 18 (03) : 159 - 167
  • [30] Coronary artery bypass surgery versus percutaneous interventions for women with multivessel coronary artery disease
    Hannan, Edward L.
    Wu, Yifeng
    Harik, Lamia
    Tamis-Holland, Jacqueline
    Jacobs, Alice K.
    Chikwe, Joanna
    Cozzens, Kimberly S.
    Gaudino, Mario
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (03):